Live feed07:05:00·4mPRReleasevia QuantisnowRoyalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from NeurimmuneByQuantisnow·Wall Street's wire, on your screen.RPRX· Royalty Pharma plcHealth Care
